Finding 390721 (2023-003)

Significant Deficiency
Requirement
B
Questioned Costs
-
Year
2023
Accepted
2024-03-31

AI Summary

  • Core Issue: The Organization lacks a consistent approval process for expenditures, risking unauthorized payments.
  • Impacted Requirements: Segregation of duties is not followed, which could lead to errors or fraud going undetected.
  • Recommended Follow-Up: Ensure a management member or Board member reviews and initials all disbursements, preventing self-approvals for reimbursements.

Finding Text

U.S. Department of Health and Human Services Health Resources and Services Administration Health Care Center Program CFDA 93.224 2023-03: Approval for expenditures Criteria: The assignment of responsibilities should be segregated so that one person is not responsible for the authorization and recording of a transaction and the custody of the related asset. Approvals should be noted on all expenditures by an individual outside of the recordkeeping and custody functions to provide reasonable assurance that transactions are allowable and appropriate for the Organization. Condition: The Organization does not consistently document an approval process on source documents for expenditure. Effect: Activities or costs that are not allowed or allowable could potentially be paid, as well as errors or intentional fraud could occur and not be detected timely by management in the normal course of their responsibilities. Cause: There are no procedures in place to ensure source documents are consistently approved by a member of management prior to payment. Identification of a repeat finding: No. Recommendation: We recommend that a member of management or the Board of Directors review and authorize all disbursements, as well as travel reimbursements. This authorization should be evidenced by the initialing of each disbursement reviewed. We also recommend that care be taken to ensure the payee is not approving reimbursements to themselves and that a member of the Board approves those reimbursements. Views of responsible officials and planned corrective actions: The Organization agrees with this finding and will adhere to the corrective action plan on page 32 in this audit report.

Corrective Action Plan

2023-03: Approval for expenditures Name of contact person: Caroline Aultman, Executive Director Corrective Action: A member of management or the Board of Directors will review and authorize all disbursements. This authorization will be evidenced by the initialing of each disbursement reviewed. Proposed completion date: The Board will implement the above procedure immediately.

Categories

Cash Management

Other Findings in this Audit

  • 390719 2023-001
    Significant Deficiency
  • 390720 2023-002
    Significant Deficiency
  • 390722 2023-004
    Significant Deficiency
  • 390723 2023-005
    Material Weakness
  • 967161 2023-001
    Significant Deficiency
  • 967162 2023-002
    Significant Deficiency
  • 967163 2023-003
    Significant Deficiency
  • 967164 2023-004
    Significant Deficiency
  • 967165 2023-005
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $587,709
93.107 Area Health Education Centers Point of Service Maintenance and Enhancement Awards $379,129